Article, see p 2344 T he Global Burden of Disease Study estimated that increased blood pressure was the world's leading risk for death, contributing to >10 million deaths in 2016.1 Hypertension is very common, with 40% of those >25 years of age having high blood pressure, representing ≈1.4 billion people worldwide.2 Almost half of those with hypertension are unaware, and although many of those who are aware are treated with antihypertensive drugs, most do not have their blood pressure lowered to recommended targets. How does China, the most populous nation in the world, fare? Wang et al 4 report in this issue of Circulation results from a large population blood pressure survey providing up-to-date data for China. The survey methods included stratified multistage random sampling to provide data representative of the Chinese population >15 years of age and the assessment of blood pressure using a standardized technique with a validated electronic manometer. Specifically, the survey was designed to examine blood pressure in 14 age-sex groups, in rural and urban settings, and in all 31 provinces of China. The survey methodology and the overall response rate of 66.4% are similar to those of other high-quality population blood pressure surveys. The survey data largely reflect global data in many regards, but in such a large population, the numbers are staggering 4 : Almost 250 million people have hypertension, >125 million are unaware, close to 150 million are not on antihypertensive drug therapy (59.3%), and "only" 37 million (15.3%) are controlled. 4 Just over 435 million (40%) adult Chinese had prehypertension. Minority ethnic populations had lower rates of awareness (36.9% versus 48.0%), treatment (29.5% versus 42.0%), and control (8.4% versus 16.1%) compared with urban populations of Han ethnicity. 4 Recently, the American College of Cardiology/American Heart Association hypertension guidelines were released, with 2 major features being a change in the definition of hypertension from 140/90 to 130/80 mm Hg and a recommendation to treat those at high cardiovascular risk who meet or exceed 130/80 mm Hg.
5Almost 50% of adults in China meet the new definition for hypertension, but a relatively small increment (≈2%) meet the new criteria to be prescribed hypertension pharmacotherapy.6 Nevertheless, the current task of identifying those who have hypertension by the 140/90 mm Hg criterion is enormous and likely to exceed primary care capacity for many years to come. Adoption of the 130/80 mm Hg criterion is likely to occur over time with a focus on identification of those at high cardiovascular risk. 6 The needless human morbidity and suffering from chronic disease led by hypertension-related diseases have been viewed as a major threat to global economic development.7 As a result, the World Health Assembly agreed to 9 targets to reduce